Skip to content

NuSkin Enterprises NUS Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

USANA Health Sciences logo
USANA Health SciencesUSNA
-$3.64M+74.8%
Herbalife logo
HerbalifeHLF
$2M+103%
The Beauty Health Company logo
The Beauty Health CompanySKIN
-$20.91M-8,262%
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
Ulta Beauty, Inc. logo
Ulta Beauty, Inc.ULTA

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's cash provided by (used in) financing activity, including discontinued operation?
NuSkin Enterprises (NUS) reported cash provided by (used in) financing activity, including discontinued operation of -$20.4M in Q1 2026.
How has NuSkin Enterprises's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
NuSkin Enterprises's cash provided by (used in) financing activity, including discontinued operation increased by 87.7% year-over-year, from -$166.3M to -$20.4M.
What is the long-term trend for NuSkin Enterprises's cash provided by (used in) financing activity, including discontinued operation?
Over 3 years (2021 to 2025), NuSkin Enterprises's cash provided by (used in) financing activity, including discontinued operation has grown at a 26.4% compound annual growth rate (CAGR), from -$104.7M to -$211.67M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.